Back to Directory Graeme Hoddinott Email graeme.hoddinott@sydney.edu.au Phone 27-21-938-9812 Institution University of Sydney Request an Update Affiliated Studies IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children DAIDS Number 38505 Research Area Tuberculosis Study Status In Development
IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children DAIDS Number 38505 Research Area Tuberculosis Study Status In Development
